Condition: Prematurity · Vascular Aging · Sponsor: Prolacta Bioscience
Early vascular aging has its origins in fetal and neonatal life. The NEOVASC clinical trial aims to determine the effects of an exclusive human milk diet in extremely preterm infants on long-term cardiovascular health.
This description comes directly from the study's public registry record.
Ursula Kiechl-Kohlendorfer, MD, MSc · +43 512 504 27309 · ursula.kohlendorfer@i-med.ac.at
Wolfgang Mitterer, MD · +43 670 2021490 · wolfgang.mitterer@student.i-med.ac.at
Always discuss trial participation with your own doctor first.
| Medical University of Innsbruck | Innsbruck, Tyrol, Austria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04413994